Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

39 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Residual SARS-CoV-2 RNA in nasal swabs of convalescent COVID-19 patients: Is prolonged quarantine always justified?
Piralla A, Ricchi M, Cusi MG, Prati P, Vicari N, Scarsi G, Gandolfo C, Anichini G, Terrosi C, Percivalle E, Vecchio Nepita E, Bergami F, Tallarita M, Di Martino R, Ferrari A, Rovida F, Lunghi G, Schiavo R, Baldanti F. Piralla A, et al. Among authors: bergami f. Int J Infect Dis. 2021 Jan;102:299-302. doi: 10.1016/j.ijid.2020.10.072. Epub 2020 Oct 30. Int J Infect Dis. 2021. PMID: 33130202 Free PMC article.
EBV DNA increase in COVID-19 patients with impaired lymphocyte subpopulation count.
Paolucci S, Cassaniti I, Novazzi F, Fiorina L, Piralla A, Comolli G, Bruno R, Maserati R, Gulminetti R, Novati S, Mojoli F, Baldanti F; San Matteo Pavia COVID-19 Task Force. Paolucci S, et al. Int J Infect Dis. 2021 Mar;104:315-319. doi: 10.1016/j.ijid.2020.12.051. Epub 2020 Dec 21. Int J Infect Dis. 2021. PMID: 33359064 Free PMC article.
Persistence of SARS-CoV-2-specific B and T cell responses in convalescent COVID-19 patients 6-8 months after the infection.
Sherina N, Piralla A, Du L, Wan H, Kumagai-Braesch M, Andréll J, Braesch-Andersen S, Cassaniti I, Percivalle E, Sarasini A, Bergami F, Di Martino R, Colaneri M, Vecchia M, Sambo M, Zuccaro V, Bruno R, Sachs M, Oggionni T, Meloni F, Abolhassani H, Bertoglio F, Schubert M, Byrne-Steele M, Han J, Hust M, Xue Y, Hammarström L, Baldanti F, Marcotte H, Pan-Hammarström Q. Sherina N, et al. Among authors: bergami f. Med. 2021 Mar 12;2(3):281-295.e4. doi: 10.1016/j.medj.2021.02.001. Epub 2021 Feb 10. Med. 2021. PMID: 33589885 Free PMC article.
SARS-CoV-2 specific T-cell immunity in COVID-19 convalescent patients and unexposed controls measured by ex vivo ELISpot assay.
Cassaniti I, Percivalle E, Bergami F, Piralla A, Comolli G, Bruno R, Vecchia M, Sambo M, Colaneri M, Zuccaro V, Benazzo M, Robotti C, Calastri A, Maiorano E, Ferrari A, Cambiè G, Baldanti F. Cassaniti I, et al. Among authors: bergami f. Clin Microbiol Infect. 2021 Jul;27(7):1029-1034. doi: 10.1016/j.cmi.2021.03.010. Epub 2021 Apr 2. Clin Microbiol Infect. 2021. PMID: 33813122 Free PMC article.
A snapshot of the immunogenicity, efficacy and safety of a full course of BNT162b2 anti-SARS-CoV-2 vaccine in cancer patients treated with PD-1/PD-L1 inhibitors: a longitudinal cohort study.
Lasagna A, Agustoni F, Percivalle E, Borgetto S, Paulet A, Comolli G, Sarasini A, Bergami F, Sammartino JC, Ferrari A, Zavaglio F, Arena F, Lilleri D, Secondino S, Falzoni M, Schiavo R, Klersy C, Lo Cascio G, Cavanna L, Baldanti F, Pedrazzoli P, Cassaniti I. Lasagna A, et al. Among authors: bergami f. ESMO Open. 2021 Oct;6(5):100272. doi: 10.1016/j.esmoop.2021.100272. Epub 2021 Sep 1. ESMO Open. 2021. PMID: 34543863 Free PMC article.
Humoral and cell-mediated response against SARS-CoV-2 variants elicited by mRNA vaccine BNT162b2 in healthcare workers: a longitudinal observational study.
Cassaniti I, Bergami F, Percivalle E, Gabanti E, Sammartino JC, Ferrari A, Adzasehoun KMG, Zavaglio F, Zelini P, Comolli G, Sarasini A, Piralla A, Ricciardi A, Zuccaro V, Maggi F, Novazzi F, Simonelli L, Varani L, Lilleri D, Baldanti F. Cassaniti I, et al. Among authors: bergami f. Clin Microbiol Infect. 2022 Feb;28(2):301.e1-301.e8. doi: 10.1016/j.cmi.2021.09.016. Epub 2021 Sep 25. Clin Microbiol Infect. 2022. PMID: 34582981 Free PMC article.
SARS-CoV-2 vaccine breakthrough infections with the alpha variant are asymptomatic or mildly symptomatic among health care workers.
Rovida F, Cassaniti I, Paolucci S, Percivalle E, Sarasini A, Piralla A, Giardina F, Sammartino JC, Ferrari A, Bergami F, Muzzi A, Novelli V, Meloni A, Cutti S, Grugnetti AM, Grugnetti G, Rona C, Daglio M, Marena C, Triarico A, Lilleri D, Baldanti F. Rovida F, et al. Among authors: bergami f. Nat Commun. 2021 Oct 15;12(1):6032. doi: 10.1038/s41467-021-26154-6. Nat Commun. 2021. PMID: 34654808 Free PMC article.
Impact of immunosuppressive treatment on the immunogenicity of mRNA COVID-19 vaccine in vulnerable patients with giant cell arteritis.
Delvino P, Bartoletti A, Cassaniti I, Bergami F, Lilleri D, Baldanti F, Bozzalla Cassione E, Biglia A, Montecucco C, Monti S. Delvino P, et al. Among authors: bergami f. Rheumatology (Oxford). 2022 Feb 2;61(2):870-872. doi: 10.1093/rheumatology/keab776. Rheumatology (Oxford). 2022. PMID: 34664631 Free PMC article. No abstract available.
Immune Response to BNT162b2 in Solid Organ Transplant Recipients: Negative Impact of Mycophenolate and High Responsiveness of SARS-CoV-2 Recovered Subjects against Delta Variant.
Cassaniti I, Bergami F, Arena F, Sammartino JC, Ferrari A, Zavaglio F, Curti I, Percivalle E, Meloni F, Pandolfi L, Pellegrini C, Turco A, Seminari E, Pattonieri EF, Gregorini M, Rampino T, Sarasini A, Lilleri D, Baldanti F. Cassaniti I, et al. Among authors: bergami f. Microorganisms. 2021 Dec 18;9(12):2622. doi: 10.3390/microorganisms9122622. Microorganisms. 2021. PMID: 34946223 Free PMC article.
39 results